| Dr Lin N Lwin, MD | |
|
4141 Carpenter Ave, Renal Unit, Bronx, NY 10466-2600 | |
| (718) 920-9041 | |
| (718) 920-9043 |
| Full Name | Dr Lin N Lwin |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 42 Years |
| Location | 4141 Carpenter Ave, Bronx, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053407031 | NPI | - | NPPES |
| 7X1731 | Other | BLUE CROSS | |
| 02048108 | Medicaid | NY | |
| P3713203 | Other | OXFORD | |
| 010113701 | Other | AMERCHOICE | |
| 218709 | Other | HIP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 218709 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bronx River Dialysis | Bronx, NY | Dialysis facility |
| Montefiore Medical Center | Bronx, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ydr Geriatrics And Nephrology, Llp | 9234020983 | 7 |
News Archive
On 3 January 2012, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with diabetes mellitus type 2.
"Health officials on Monday celebrated a faster treatment for people who have tuberculosis but aren't infectious, after investigators found a new combination of pills knocks out the disease in three months instead of nine," the Associated Press/Seattle Times reports.
Most of our serious problems in the world today can be traced back to the impact of human populations on the environment. With each person requiring energy, space and resources to survive, the stress on the planet of the world population, currently estimated to be seven billion, is enormous.
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed for Focalin XR (dexmethylphenidate hydrochloride) extended-release capsules, 5mg, 10mg, 15mg & 20mg. Focalin XR is manufactured for the U.S. for Novartis Pharmaceuticals Corporation by Elan Holdings Inc.
Malaria is one of the most deadly infectious diseases in the world today, claiming the lives of over half a million people every year, and the recent emergence of parasites resistant to current treatments threatens to undermine efforts to control the disease. Researchers are now onto a new strategy to defeat drug-resistant strains of the parasite. Their report appears in the journal ACS Chemical Biology.
› Verified 4 days ago
| Entity Name | Ydr Geriatrics & Nephrology, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417020058 PECOS PAC ID: 9234020983 Enrollment ID: O20040322001916 |
News Archive
On 3 January 2012, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with diabetes mellitus type 2.
"Health officials on Monday celebrated a faster treatment for people who have tuberculosis but aren't infectious, after investigators found a new combination of pills knocks out the disease in three months instead of nine," the Associated Press/Seattle Times reports.
Most of our serious problems in the world today can be traced back to the impact of human populations on the environment. With each person requiring energy, space and resources to survive, the stress on the planet of the world population, currently estimated to be seven billion, is enormous.
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed for Focalin XR (dexmethylphenidate hydrochloride) extended-release capsules, 5mg, 10mg, 15mg & 20mg. Focalin XR is manufactured for the U.S. for Novartis Pharmaceuticals Corporation by Elan Holdings Inc.
Malaria is one of the most deadly infectious diseases in the world today, claiming the lives of over half a million people every year, and the recent emergence of parasites resistant to current treatments threatens to undermine efforts to control the disease. Researchers are now onto a new strategy to defeat drug-resistant strains of the parasite. Their report appears in the journal ACS Chemical Biology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lin N Lwin, MD Po Box 1239, Scarsdale, NY 10583-9239 Ph: (914) 636-8591 | Dr Lin N Lwin, MD 4141 Carpenter Ave, Renal Unit, Bronx, NY 10466-2600 Ph: (718) 920-9041 |
News Archive
On 3 January 2012, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with diabetes mellitus type 2.
"Health officials on Monday celebrated a faster treatment for people who have tuberculosis but aren't infectious, after investigators found a new combination of pills knocks out the disease in three months instead of nine," the Associated Press/Seattle Times reports.
Most of our serious problems in the world today can be traced back to the impact of human populations on the environment. With each person requiring energy, space and resources to survive, the stress on the planet of the world population, currently estimated to be seven billion, is enormous.
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed for Focalin XR (dexmethylphenidate hydrochloride) extended-release capsules, 5mg, 10mg, 15mg & 20mg. Focalin XR is manufactured for the U.S. for Novartis Pharmaceuticals Corporation by Elan Holdings Inc.
Malaria is one of the most deadly infectious diseases in the world today, claiming the lives of over half a million people every year, and the recent emergence of parasites resistant to current treatments threatens to undermine efforts to control the disease. Researchers are now onto a new strategy to defeat drug-resistant strains of the parasite. Their report appears in the journal ACS Chemical Biology.
› Verified 4 days ago
Selina Sultana Zaman, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 718-920-9000 | |
Dr. Jyothi B Kudakandira, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-960-1234 | |
Mana Rao, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Dr. Keshav Teelucksingh, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Tannaz Iranpour Boroujeni, M.D Nephrology Medicare: May Accept Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 617-840-0110 | |
Heather Root, MD Nephrology Medicare: May Accept Medicare Assignments Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-920-8592 Fax: 718-405-0610 | |
Benjamin Tuttle Hayes, MD Nephrology Medicare: May Accept Medicare Assignments Practice Location: 305 E 161st St, Bronx, NY 10451 Phone: 718-579-2500 Fax: 718-579-2599 |